201. Comparison of filter life span and solute removal during continuous renal replacement therapy: convection versus diffusion ‐ A randomized controlled trial.
- Author
-
Xu, Qiancheng, Jiang, Bo, Li, Juan, Lu, Weihua, and Li, Jianguo
- Subjects
RENAL replacement therapy ,LIFE spans ,RANDOMIZED controlled trials - Abstract
Introduction: This study aimed to investigate whether continuous veno‐venous hemodiafiltration (CVVHDF) has a different filter life span and molecular solutes clearance when compared to continuous veno‐venous hemofiltration (CVVH). Methods: Sixty patients were enrolled in this study and randomly assigned to the CVVHDF (n = 30) or CVVH (n = 30) groups. Demographics, laboratory tests, urea, creatinine, IL‐6, β2‐microglobulin, and myoglobulin clearance were recorded. Results: Patients in the CVVH group had a shorter median time of filter life span compared with those in the CVVHDF group (20 vs. 37.5 h, p = 0.002). Urea and creatinine clearance were not significantly different between groups over time (p > 0.05). IL‐6, β2‐microglobulin, and myoglobulin clearance were higher in the CVVH group. The transmembrane pressure (TMP) was significantly higher in the CVVH group. Conclusion: The use of CVVHDF may lead to a longer filter life span and lower clearance of medium and large molecules without affecting the small molecular solute clearance. Trial registration: Chinese Clinical Trial Register (ChiCTR), ChiCTR2000029873. Registered 16 February 2020, http://www.chictr.org.cn/showproj.aspx?proj=49528 [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF